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Abstract  
The mammalian cerebral neocortex is a complex six-layered structure containing 
multiple types of neurons. Pyramidal neurons of the neocortex are formed during 
development in an inside-out manner, by which deep layer (DL) neurons are generated 
first, and upper layer (UL) neurons are generated last. Neurons within the six-layered 
neocortex express unique markers for their position, showing whether they are 
subplate, deep layer, upper layer, or Cajal-Retzius neurons. The sequential generation 
of cortical layers, which exists in vivo, has been partially recapitulated in vitro by 
differentiation of mouse embryonic stem cells (Gaspard et al., 2008) and human 
embryonic stem cells (hESC) (Eiraku et al., 2008). The timeline of generation of cortical 
neurons from hESC is still not well defined, and could be very important in the future 
of cell therapy.  In this study we will define timeline for UL and DL neurons for our 
experimental paradigm as well as test the effects of fibroblast growth factors (FGF) 2 
and 8 on this neuronal differentiation. Recent papers suggest that FGFs are critical for 
forebrain patterning (Storm et al., 2003). Neuronal differentiation after treatment with 
either FGF2 or FGF8 from hESCs will be examined and the proportion of specific 
neuronal markers will be analyzed using immunocytochemistry. Our results show that 
the generated pyramidal neurons will express DL and UL laminar markers in vitro as 
they do in vivo and that the presence of FGF8 in induction media creates a proliferative 
effect, while FGF2 induces hESC to differentiate at a higher rate. 
 
Introduction 
The study of human embryonic stem cells (hECS) their pluripotent potential is 
leading to immense possibility in the future of medicine. hESCs have the ability to 
differentiate into a variety of tissue cells when indicated to do so, including neurons. To 
be able to differentiate into neurons, hESCs must be induced into a neuronal fate in 
vitro. This could be achieved by subjecting the cells to a serum-free induction media 
with growth factors that allow them to take on the potential for neuronal 
differentiation. To start neuronal induction and differentiation, hESCs grown on 
irradiated mouse embryonic fibroblast (irrMEF) feeder cells should be mechanically 
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scraped off and placed in a suspension of induction media, in which they create clusters 
called embryoid bodies (EBs). After proliferating as EBs, they should be plated on an 
adhesion surface to flatten and form neural tube shaped groups of cells termed 
‘rosettes’ that express early neuroectodermal markers such as Pax6 and Sox1 (Elkabetz 
et al., 2008). Once at rosette stage, the cells are at their highest potential for wide variety 
differentiation. It has been shown that by implanting rosette cells in vivo, they 
incorporate themselves into the brain and will test positive for β3-tubulin and nestin, 
two neurogenenic markers (Zhang et al., 2001) In vitro, these neuronal precursor cells 
have the ability to develop into different types of neurons when placed in environments 
with specific growth factors. It is important to isolate rosette cells and either freeze or 
differentiate them at this point (Elkabetz et al., 2008). 
 
We introduced fibroblast growth factor 2 (FGF2) to embryoid bodies and then 
divided them into two groups.  The cultures are then plated as rosettes on poly-D-lysine 
and laminin substrates and treated with either FGF2 or FGF8. Fibroblast growth factors 
are proteins that control embryonic neurogenesis by binding receptor tyrosine kinases 
in high-affinity, which subsequently activates multiple signal transduction pathways 
(Storm et al., 2001). FGF2 has been shown to increase the dendritic growth, migration 
and survival of neural stem cells while developing (Vergaño-Vera et al., 2009), while 
also being crucial to the proliferation of neuroepithelial cells (Zhang et al., 2001.)  
 
At rosette stage, cells will be treated with either FGF2 or FGF8. Because of the 
inclusion of FGF2 or FGF8 in the medium, the majority of these progenitors are 
expected to produce forebrain pyramidal cells. FGF2 has been proven to allow an 
improvement of cell growth and colony quality (Zhang et al., 2001). It also directs 
developing neurons to be more forebrain specified. FGF8 is essential to the normal 
development of the forebrain; it is mainly expressed along the rostral-most point of the 
neural ridge, where most pre-anterior forebrain progenitors reside (Storm et al. 2003). 
Both FGF-2 and FGF-8 will be compared by observing the effect they have on the 
differentiation phase of the neuronal maturation.  
 
After rosette isolation, differentiation will be initiated. Addition of neuronal growth 
factors, neurotrophin 3 (NT3) and brain derived neurotrophic factor (BDNF) in the cell 
culture serum-free media induces differentiation. Neuronal progenitor cells have 
intrinsic signaling, allowing them to follow natural corticogenesis in vitro (Gaspard et 
al., 2008). Pyramidal neurons, anterior and posterior, are characterized by their 
monoaxonal shape, excitable behavior and specific markers (Gaspard et al., 2008). They 
develop from progenitors in the ventricular zone (VZ), and then migrate to deeper and 
upper cortical layers. When mature, neurons are found in six different cortical layers. 
DL neurons express signaling genes such as CTIP2 and Sox5, while upper layer neurons 
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express SATB2 and CUX1 (Fig. 1)(Gaspard et al., 2008, Leone et al., 2008)(Fig. 1). Using 
in vitro studies to observe presence of the layer-unique markers allows the possibility 
create and quantify a natural model of corticogenesis.  This marking method gives the 
ability to identify a timeline of pyramidal neuron positioning. Our goal is to create layer 
specific pyramidal neurons from hESC and quantify them using immunocytochemistry 
with the important laminar markers (Fig. 1). 
 
Reproducing this natural timeline of hESCs through pyramidal neurons includes the 
difficulties of cell culture as well as the precise timing by which the hESCs and 
subsequent developing neurons must be in the presence of specific brain factors in 
order to mirror corticogenesis in vivo. The intrinsic neocorticogenesis patterning has 
been found, but mechanisms are still largely unknown. By following the induction and 
differentiation neuronal media process with these neuronal factors as well as FGF2 and 
FGF8, it will be possible to observe the fate of neurons derived from stem cells leading 
to mechanistic clues and methods for future therapy. In the future, this study will allow 
a better understanding of  cortical layer mapping in vitro and the effects of fibroblasts 
growth factors 2 and 8 on the process of differentiation.  
Methods    
hESC culture and Induction of neuronal cell fate 
Human Embryonic Stem Cell line (H9, University of Connecticut Health Center 
Stem Cell Core) was grown on top of irrMEF for approximately 1 week (n=3). The 
colonies were then scraped off and grown as a suspension in hESC media [(DMEM/F12, 
knockout serum replacer (KSR), ß-mercaptoethanol, 2mM L-glutamine, nonessential 
amino acids (NEAA)] to form free-floating aggregates. After 4 days, the aggregates 
were switched into high concentration FGF2 containing media (8ng/mL). After the total 
Figure 1. Layer markers of the developing cortex. This 
diagram shows the markers characteristic of neurons 
in different cortical layers. Main deep layer markers 
include CTIP2, SOX5 and TRB1 where as upper layer 
neurons are marked for SATB2 and CUX1 (taken 
from Gaspard et al., 2008). 
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EB propagation for 8 days, the cell aggregates were transferred onto poly-D lysine  and 
laminin coated plates for adhesion and rosette formation. At this point, the cells were 
switched into neuronal induction media (DMEM/F12, N2 supplement, B27 supplement, 
2mM L-glutamine, 4ng/mL FGF) to start priming the cells for neuronal fate. Half of the 
cells were placed in NIM FGF2 (4ng/mL) and the other half in NIM FGF8 (4ng/mL). 
Cells were proliferated until rosette-shaped colonies were formed (Fig 2).  
 
 
Differentiation of neurons from hESC 
After 7 days in NIM with FGF2 or FGF8, the rosettes were digested with trypsin 
and plated as monolayer cultures on laminin-coated plates in NIM with FGF2 or FGF8 
with Y-27632 (4ng/mL), a ROCK inhibitor (Fig 2). After one day to adhere, the 
monolayer cultures were switched to NT3 differentiation medium (DMEM/F12, 2mM L-
glutamine, N2 and B27 supplements, NT3 [20ng/mL], BDNF [20ng/mL]). These cells 
were then fixed and stained on day 7, 14 and 21 from the start of differentiation.  
 
 
. 
Immunocytochemistry  
Cell cultures (n=3) were fixed with 4% paraformaldehyde every 7, 14 and 21 
days. After being rinsed with PBS, a blocking solution containing 5% normal goat 
serum (NGS) and 0.5% Triton-100 was placed on the coverslips for 30 minutes followed 
by incubation with primary antibodies (overnight, RT) and secondary antibodies (2h, 
dark RT). The coverslips were then mounted using Vectasheild mounting serum. The 
primary antibodies are presented in Table 1:  
 
Figure 2. Experimental 
plan to follow for hESC 
proliferation and 
differentiation. Floating 
cell aggregates are made at 
week 1, plated to form 
rosettes at week 2 and then 
trypsinized and plated in 
differentiation media at 
week 3. 
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After incubation with primary antibodies, cells were washed with PBS, and the 
secondary antibodies were added. The secondary antibodies consisted of either goat 
anti-rabbit IgG Alexa 488 conjugated with fluorescein (1:200, Invitrogen) or goat anti-
mouse IgG Alexa 568 . For nuclear staining cells were incubated with ToPro (1:1000, 
Invitrogen) or/and DAPI.  
 
Quantification  
Cells were viewed under a tabletop Nikon fluorescent microscope or Laica confocal 
microscope. Each set of cells from days 7,14 and 21 were quantified for the neuronal 
markers expressed at each time point. The number of β-III tubulin, an immature 
neuronal marker, was expressed as a percentage of total cells, stained with DAPI. Five 
random fields were quantified under 20X magnification. 
Results  
Two full rounds of cell cultures were completed allowing us to compare and 
contrast the effects of FGF2 and FGF8. hECS (H9, University of Connecticut 
Health Center Stem Cell Core) were successfully grown on irrMEF. They began 
as sharp edged cells with small colonies (Fig. 3A), grew into large, 
undifferentiated colonies (Fig. 3B) and were ready to be mechanically lifted and 
grown as undifferentiated cell aggregates, or embryoid bodies, for 8 days (Fig. 
3C). 
 
Primary 
antibody 
Labeling Type of 
antibody 
Dilution 
β3-tubulin Immature 
neurons 
Anti-
mouse IgG 
1:200 
Ctip2 Deep layer 
neurons 
Anti-rabbit 
IgG 
1:200 
SATB2 Upper layer 
neurons 
Anti-
mouse IgG 
1:200 
Sox5 Deep layer 
neurons 
Anti-rabbit 
IgG 
1:200 
Oct3/4 Stem cells Anti-rabbit 
IgG 
1:200 
Pax6 Neuroectodermal 
marker 
Anti 
mouse-IgG 
1:200 
Nestin Neural stem cells Anti-
mouse IgG 
1:200 
Table 1. Primary antibodies for 
immunocytochemistry. Table includes: 
Abbreviated name of protein stained, 
where this protein is expressed during 
development, type of immunoglobulin 
antibody, and working dilution factor. 
 
Figure 3. Human embryonic stem cells in 
culture. Plated on irradiated mouse 
fibroblasts, hESCs begin as single cells and 
then form small colonies (A). (B) is a larger 
colony of hESCs ready to be transferred into 
a floating aggregate media. These floating 
undifferentiated aggregates are shown in (C) 
called neurospheres (NS). 
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The embryoid bodies (EB) were then plated on a poly-D lysine substrate to 
flatten as rosettes in neural induction media. Rosettes showed neural tube 
morphology (Fig. 4A,B), as well as neuronal precursor staining of nestin (Fig. 
4C), Pax 6 (paired box gene), a gene regulating early progenitors to project to 
telencephalic neocortex (Molyneaux et al.,2007, Eiraku et al., 2008) (Fig. 4D), and 
Otx2 (orthodenticle homeobox 2)(Fig. 4E).  
 
Figure 4. Immunocytochemical  
representation of rosettes. (A) and (B) 
  are contrast images showing  
rosette morphology and neural tube 
 similarity. Nestin expression for  
staining for neuron precursors is present 
 (C), (D) for Pax6 and(E) Otx2 protein 
 staining. 
 
 7 
 Laminar marker expression visualized via immunocytochemistry allowed us 
to track the DL or UL position of the differentiated cells. After one week in neuronal 
differentiation media with NT3 (20ng/mL) and BDNF (20ng/mL), almost all cells 
expressed nestin (Fig. 5A,B). Nestin is expressed in neuronal precursor cells and cells 
that are dividing during early development of the CNS and down-regulates after 
differentiation. It is clear that these cells are still undifferentiated. β3-tubulin, an 
immature neuronal marker, which would show differentiation, is expressed very 
rarely (Fig. 5D). DL laminar markers Ctip2 and Sox5 have begun to express, as shown 
in Fig. 5 B-D. CTIP2, (COUP-TF) interacting protein 2, plays a dynamic role in the 
axonal extension and growth of the correct pathway during development of the 
cerebral cortex (Arlotta et al., 2008). During first week in differentiation media 
culture, only CTIP2+ neurons are detected (30±3.8%)(Fig. 7). The expression of this 
protein is strong at one week and Sox 5, another DL marker involved in the neuronal 
subtype specificity (Lai et al., 2008) is less prevalent and weaker when compared to 
the cells fixed at two weeks (Fig. 6B,C). 
 
In the second week of differentiation, the percentage increased (55±14.9%) and Satb2+ 
upper layer neurons appeared (2.2 
±1.9%)(Fig. 6B, 7) and Sox5, which was not 
expressed in every cell at week one, is now 
widespread, showing development (Fig 
6C). It is clear that there is strong β3-
tubulin in cells from week 2, shown in 
Figure 6 B-D. The Satb2+ cells along with 
strong DL neuronal expression 
Figure 5. Expression of neuronal  
precursor and laminar markers at  
week one in differentiation media.  
Nestin, expressed in neuronal precursors, 
 is present in almost all cells from week 
 1 of differentiation showing lack of or 
premature differentiation (A). DL  
marker Ctip2 is expressed (B), as well 
 as a weaker expression of DL marker  
Sox5 (C,D). A single differentiated cell, 
 (D, top left, arrow), is shown by 
 expression of β3-tubulin. 
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demonstrates temporal appearance of cortical neurons in vitro from hESC. 
 
 
 
 
 
 
 
In a previous study, it was shown that FGF8 is critical in development of the 
anterior forebrain (Storm et al., 2003) and FGF2 is crucial to forebrain neuronal 
preparation (Zhang et al., 2001).  By adding these separate fibroblast growth factors to 
the induction media, we came across interesting observations. We tested this as well 
as the fate of neurons based on their layer specifications. Under identical conditions 
there were general differences in the general health and behavior of the cultured cells. 
FGF2 cells aggregated much more with fewer cells in culture than FGF8. However, 
cells with FGF8 administration showed far less differentiated morphology and a 
smaller number of β3-tubulin+ immature neurons was noticed in these cultures (Fig. 
8A-D). With induction media containing FGF2, at week 2 in differentiation media 
there was a average percentage of 7.5%±4.9 expression of β3-tubulin compared to the 
total number of cells shown by DAPI/ToPro expression (n=3). FGF8 inhibited this 
Figure 6. Expression of laminar markers of 
differentiated neurons at week two. Early 
 neuronal differentiation is expressed at two  
weeks by RFP staining of β3-tubulin in all cells 
 (B,C). DL marker, Ctip2, has decreased in 
 strength (B), while Sox5 is expressed in every  
cell at two weeks (C). Most importantly,  
UL neuron marker Satb2 is expressed in cells  
at two weeks (D, arrows).  
 
 
Fig.7. Graphical representation  
of percentages of upper and deep layer cortical 
neurons in vitro. 
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much expression of β3-tubulin, only allowing 2.5%±.7 to express β3-tubulin (n= 3) 
(Fig. 8D). Furthermore, in week 3, there was an average of 23.3%±12 β3-tubulin 
expressing cells in FGF2 affected cells (n=4) and only a average of 1.2%±.8 from FGF8 
cells (Fig. 8D). These data show that the FGF2 cells differentiated in a higher degree, 
while FGF8 cells proliferated instead; the cells would still retain the original β3-
tubulin expression if they had previously differentiated. FGF2 induced differentiating 
cells to cluster into small colonies, showing high expression of β3-tubulin (Fig. 8B). In 
contrast, FGF8 kept cells in a monolayer, singlized culture, with few differentiated 
cells that had long bipolar processes (Fig. 8A).  
 
 
Figure 8. Effects of FGF2 or FGF8 on hESC differentiation into pyramidal neurons. Cells affected with FGF8 
show more proliferation, as with TOPRO cell body staining, and few cells differentiating into neurons stained 
with β3-tubulin (A). FGF2 (B,C) increases the amount of differentiated cells by showing clumps of neurons in 
which β3-tubulin is strongly expressed. From week 2 to week 3, the percentage of β3-tubulin expressing cells 
affected with FGF2 increased from 7.5%±4.9 to 23.3%±12, showing differentiation (D); that percentage increase 
was not found in FGF8 cells. Cells affected with FGF8 showed a decrease from 2.5%±.7 at week 2 to 1.2%±.8 at 
week 3, showing massive undifferentiated cell proliferation (D). 
Discussion 
Human embryonic stem cells are a popular focus of current research studies. 
Their ability to differentiate into brain cells, bone cells, muscle cells, and epithelial 
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cells with the proper extrinsic signaling opens wide doors to possibilities of helping 
devastating diseases without present cures. In this study we described in vitro 
generation of neocortical neurons from human embryonic stem cells and the effect of 
two growth factors, FGF2 and FGF8 on their differentiation. Major findings of the 
study are as follows: 1. Human cortical neurons follow the same temporal pattern of 
generation in vitro, as in vivo; 2. Two members of the FGF family, FGF2 and FGF8 have 
differential effect on neuronal differentiation when added in early phase of cell 
culture, during neuronal induction.  
Acknowledging the fact that a human brain develops slower, this study shows 
in humans what Gaspard et al., 2008, discovered in rodents. Gaspard’s previous study 
showed that nestin down-regulated in between day 14 and 21 in mouse. Our images 
show that the down regulation begins week 2, or day 29 including EB culture (8days) 
and rosette formation (7days), showing an initiation of differentiation 2 weeks behind 
rodent down-regulation. Human stem cells are important to research because this 
difference between mouse and human stem cell development is very different. 
Humans, because of an extended lifespan, have more delayed dividing of embryonic 
stem cells than of a mouse. Downstream of slower division means later differentiation 
and expression of laminar markers, perhaps withholding the expression of Sox5 in 
human ES cells. So far, are not studies except one (Eiraku et al., 2008) which focused 
on the laminar specification of neurons derived from hESC. 
 
 In cortex deep layers 5 and 6, neurons express Ctip2 and Sox5 (Leone et al., 
2008). After week one in differentiation media (NT3, BDNF 20ng/mL), Ctip2 was 
expressed in 30% of cells, showing that after week 1 of differentiation, 22 days in 
culture, there was axonal growth from forebrain DL neurons. In comparison, this is 
earlier than Eiraku et al.. Sox5 was weakly expressed at week one, or day 22 after EB 
formation, and widespread in week 2, day 29. The probable reason for the difference 
in expression is the difference between human and rodent neuronal development.  
 
The 2008 study of Eiraku et al., which shows DL staining of human neurogenic 
markers, did not describe UL markers of neurons developed from hESC. Our study 
shows Satb2 was shown to express after 2 weeks in differentiation media (29 days). 
Staining at week one for Satb2 (not shown) was negative, showing later expression 
and the presence of more mature neurons. Neurons that have migrated to the upper 
layers of the cortex express Satb2 and also Cux1 (not shown.) Satb2 is expressed in 
neurons in layers 2-4 that have projected into the cortical plate (Leone et al., 2008, 
Alcamo et al., 2008). This data and our experiment that shows Satb2 was expressed in 
a few cells after two weeks of differentiation media proves that these differentiated 
progenitor cells could now be layer 4 neurons. In sequence with Gaspard et al., it 
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follows that Satb2 would be expressed at 29 days in human as it was expressed in 
mouse at day 12, taking into account the delayed brain development in humans. This 
exemplifies the in vivo recapitulation of human ES cell differentiation in vitro.  
 
The growth factors FGF2 and FGF8 have been shown to regulate neocortical 
patterning in neuronal progenitors. In the study of Storm et al. from 2003, it was 
found that an elimination or high dosage of FGF8 produced an apoptotic effect, where 
as lowering the dosage increased cell survival in rodent neuronal progenitors. Here 
we used a low dosage (4ng/mL) and showed that only 1.2% of cells differentiated into 
β3-tubulin neurons, in high contrast with the 23.3% from cells treated with FGF2. A 
more recent study by Storm et al. in 2006 showed that FGF8 mutations led to 
abnormal telencephalon development due to decreased cell survival and increased 
cell death, proving that FGF8 does have significant proliferative effects. While FGF2 is 
expressed throughout the developing CNS, FGF8 is tightly localized to specific 
regions of the developing brain and is expressed only in the embryo during early 
phases of proliferation and neurogenesis. FGF8 is expressed first at the rostral most 
point of the neural plate and then following neural tube closure, in the rostral midline 
of the telencephalon. FGF8 has a role in initial patterning of mouse telenceplalon, but 
also in anterior-posterior patterning of the brain (Storm et al., 2003, Fukushi-
Shigomori et al., 2001). Our future studies will test for this anterior-posterior 
patterning and progenitor projection when treated with FGF8 by focusing on markers 
such as BF-1, Otx2, Emx1 in rostral telencephelon, and COUP-TF1 in caudal 
telencephelon. By treating with varying dosages of FGF2 vs. FGF8, the underlying 
rostral or caudal fate of neuronal progenitors could be directed for future therapies. 
 
In summary, this study developed a reproducible method for the production of 
DL and UL neurons in vitro, and shown that FGF2 has a more potent effect for 
directing neuronal progenitors toward differentiation than FGF8. While not the only 
significant reason for this study, an example to recreate neurons of specified layers is 
to assist in the therapy of amyotrophic lateral sclerosis (ALS). UL neurons send 
projections to subcortical targets, spine, pons, thalamus, and DL neurons send their 
dendrites of sensory-motor cortex to corticospinal neurons. In ALS, these neurons 
degenerate. With the specificity of neuronal cortical layering shown, the necessary 
human stem cell differentiation for the degeneration characteristic of ALS is possible 
in the future, making this study very relevant to potential therapies for degenerative 
diseases like ALS. 
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